Scientific publications
- [COMBINATION STRATEGIES FOR TRANSLATIONAL IMMUNOTHERAPY]
- [CYTOKINE-BASED THERAPEUTICS]
- [IMMUNOLOGY AND IMMUNOTHERAPY]
- [LOCOREGIONAL IMMUNOTHERAPY STRATEGIES IN PERITONEAL CARCINOMATOSIS]
Revisiting intracavitary immunotherapy of cancer. Scientific Publication
May 13, 2022
| Magazine: Clinical Cancer Research
Fernando Aranda 1 , Iñaki Eguren-Santamaria 2 , Angela Bella 1 , Pedro Berraondo 1 , Ignacio Melero 3
Abstract
Ovarian cancer is often limited to the peritoneal cavity in the form of peritoneal carcinomatosis. Peritoneal spreading offers the opportunity for locoregional delivery of combinations of immunotherapy agents, maximizing bioavailability while potentially reducing systemic exposure and side effects.
CITATION Clin Cancer Res. 2022 May 13;28(10):1993-1995. doi: 10.1158/1078-0432.CCR-22-0201.
Our authors
Researcher | Principal Investigator
Research Group on Locoregional Immunotherapy Strategies in Peritoneal Carcinomatosis
Researcher | Principal Investigator
Combination Strategies for Translational Immunotherapy Research Group
Researcher | Principal Investigator
Cytokine-Based Therapeutics Research Group
